A prospective randomized trial comparing corifollitropin-α late-start (day 4) versus standard administration (day 2) in expected poor, normal, and high responders undergoing controlled ovarian stimulation for IVF-Reference-Cited by-同舟云学术

A prospective randomized trial comparing corifollitropin-α late-start (day 4) versus standard administration (day 2) in expected poor, normal, and high responders undergoing controlled ovarian stimulation for IVF

Published:2020-03-18 Issue:5 Volume:37 Page:1163-1170
ISSN:1058-0468
Container-title:Journal of Assisted Reproduction and Genetics
language:en
Short-container-title:J Assist Reprod Genet

Author:

Revelli Alberto,Gennarelli Gianluca,Sestero Marta,Canosa Stefano,Carosso Andrea,Salvagno Francesca,Pittatore Giulia,Filippini Claudia,Benedetto Chiara

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Developmental Biology,Obstetrics and Gynecology,Genetics,Reproductive Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10815-020-01742-5.pdf

Reference24 articles.

1. Fares FA, Suganuma N, Nishimori K, LaPolt PS, Hsueh AJ, Boime I. Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit. Proc Natl Acad Sci U S A. 1992;89(10):4304–8.

2. LaPolt PS, Nishimori K, Fares FA, Perlas E, Boime I, Hsueh AJ. Enhanced stimulation of follicle maturation and ovulatory potential by long acting follicle-stimulating hormone agonists with extended carboxyl-terminal peptides. Endocrinology. 1992;131(6):2514–20.

3. Fauser BCJM, Mannaerts BMJL, Devroey P, Leader A, Boime I, Baird DT. Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency. Hum Reprod Update. 2009;15(3):309–21.

4. Revelli A, Pittatore G, Casano S, Canosa S, Evangelista F, Benedetto C. Efficacy and safety of late-start Corifollitropin-alfa administration for controlled ovarian hyperstimulation in IVF: a cohort, case-control study. J Assist Reprod Genet. 2015;32(3):429–34.

5. Brandes M, van der Steen JOM, Bokdam SB, Hamilton CJCM, de Bruin JP, Nelen WLDM, et al. When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility population. Hum Reprod. 2009;24(12):3127–35.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Corifollitropin Alfa for Controlled Ovarian Stimulation in Assisted Reproductive Technologies: State of the Art;Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics;2023-01

2. Clinical outcomes in patients receiving originator follitropin alfa and follitropin alfa biosimilars in real-world clinical practice: A retrospective study;Journal of Human Reproductive Sciences;2023

3. Relation of serum and follicular level of BMP15 with Oocyte quality, embryo grading and pregnancy rate;Journal of Contemporary Medical Sciences;2022-10-26

4. Effect of rLH Supplementation during Controlled Ovarian Stimulation for IVF: Evidence from a Retrospective Analysis of 1470 Poor/Suboptimal/Normal Responders Receiving Either rFSH plus rLH or rFSH Alone;Journal of Clinical Medicine;2022-03-13

5. Evaluating different strategies for poor ovarian response management: a retrospective cohort study and literature review;Annals of the New York Academy of Sciences;2021-05-27